Analysts expect Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX – Get Rating) to report $0.18 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Allscripts Healthcare Solutions’ earnings, with the highest EPS estimate coming in at $0.21 and the lowest estimate coming in at $0.17. Allscripts Healthcare Solutions posted earnings of $0.23 per share during the same quarter last year, which suggests a negative year over year growth rate of 21.7%. The firm is expected to report its next quarterly earnings results on Monday, January 1st.
On average, analysts expect that Allscripts Healthcare Solutions will report full-year earnings of $0.85 per share for the current year, with EPS estimates ranging from $0.76 to $0.99. For the next financial year, analysts anticipate that the firm will report earnings of $0.88 per share, with EPS estimates ranging from $0.72 to $1.02. Zacks’ earnings per share averages are an average based on a survey of sell-side analysts that cover Allscripts Healthcare Solutions.
Allscripts Healthcare Solutions (NASDAQ:MDRX – Get Rating) last posted its quarterly earnings data on Thursday, May 5th. The software maker reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.13 by ($0.04). Allscripts Healthcare Solutions had a return on equity of 10.97% and a net margin of 11.60%. The firm had revenue of $142.70 million for the quarter, compared to analyst estimates of $139.67 million. During the same period in the prior year, the company earned $0.13 earnings per share. The firm’s quarterly revenue was up 6.7% on a year-over-year basis.
Several research analysts recently commented on the company. Deutsche Bank Aktiengesellschaft raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and increased their price target for the company from $20.00 to $26.00 in a research report on Friday, March 4th. Zacks Investment Research cut Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating and set a $23.00 price target for the company. in a research report on Tuesday, March 29th. Piper Sandler reduced their price target on Allscripts Healthcare Solutions from $22.00 to $19.00 in a research report on Friday, May 6th. StockNews.com cut Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research report on Friday, May 13th. Finally, SVB Leerink raised their price objective on Allscripts Healthcare Solutions from $22.00 to $24.00 and gave the company an “outperform” rating in a research report on Thursday, March 3rd. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $22.00.
In other Allscripts Healthcare Solutions news, CEO Paul Black sold 60,000 shares of the firm’s stock in a transaction on Thursday, March 10th. The stock was sold at an average price of $21.87, for a total transaction of $1,312,200.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Elizabeth Ann Altman sold 6,028 shares of the firm’s stock in a transaction on Friday, May 27th. The stock was sold at an average price of $16.75, for a total value of $100,969.00. Following the transaction, the director now owns 22,796 shares in the company, valued at approximately $381,833. The disclosure for this sale can be found here. In the last quarter, insiders have sold 177,565 shares of company stock worth $3,435,419. 2.29% of the stock is owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. boosted its holdings in shares of Allscripts Healthcare Solutions by 9.3% during the 4th quarter. BlackRock Inc. now owns 23,846,502 shares of the software maker’s stock valued at $439,969,000 after acquiring an additional 2,028,119 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Allscripts Healthcare Solutions by 4.4% in the 1st quarter. Vanguard Group Inc. now owns 13,852,474 shares of the software maker’s stock worth $311,957,000 after acquiring an additional 584,339 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Allscripts Healthcare Solutions by 87.7% in the 4th quarter. JPMorgan Chase & Co. now owns 7,467,089 shares of the software maker’s stock worth $137,767,000 after acquiring an additional 3,488,947 shares in the last quarter. Fisher Asset Management LLC increased its position in Allscripts Healthcare Solutions by 0.6% in the 4th quarter. Fisher Asset Management LLC now owns 5,640,456 shares of the software maker’s stock valued at $104,066,000 after buying an additional 35,230 shares in the last quarter. Finally, Wellington Management Group LLP increased its position in Allscripts Healthcare Solutions by 4.0% in the 3rd quarter. Wellington Management Group LLP now owns 5,178,710 shares of the software maker’s stock valued at $69,238,000 after buying an additional 201,335 shares in the last quarter.
NASDAQ MDRX traded up $0.02 during trading hours on Wednesday, hitting $17.11. 11,628 shares of the company traded hands, compared to its average volume of 1,621,309. The business’s 50-day moving average is $20.33 and its 200-day moving average is $19.52. Allscripts Healthcare Solutions has a twelve month low of $13.05 and a twelve month high of $23.25. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.38 and a current ratio of 2.38. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of 15.31, a P/E/G ratio of 1.49 and a beta of 0.98.
Allscripts Healthcare Solutions Company Profile (Get Rating)
Allscripts Healthcare Solutions, Inc, together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Allscripts Healthcare Solutions Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com’s FREE daily email newsletter.